Search

everythinglearnresearchcommunity

for

Search:↓

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Blood count parameters are not reliable for predicting recurrent implantation failure.

Finasteride can help induce ovulation and lead to a healthy birth in some women.

AMH is a reliable marker for diagnosing PCOS.

Women with pituitary adenomas often have reproductive issues, like irregular periods and trouble getting pregnant, but not always breast milk production without pregnancy.

The conclusion is to diagnose PCOS with just hyperandrogenism and irregular periods, and treat with lifestyle changes and basic medications.

PRP injections did not significantly improve ovarian function in women with low ovarian reserve.

A 15-year-old girl with missed periods was diagnosed with a pituitary disorder and treated with hormones and steroids.

Accurate diagnosis of PCOS requires comprehensive androgen measurement.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.

Late onset of first period and irregular development of sexual traits in teenage girls can lead to poorer reproductive health.

Hyperprolactinemia is the most common cause of secondary amenorrhea, followed by drug use.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Women with PCOS have different hormone levels compared to those without PCOS.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Early diagnosis and personalized treatment of PCOS improve quality of life and prevent complications.

Including ovarian morphology in diagnosis increases PCOS prevalence estimates, highlighting the need for standardized criteria.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Polycystic ovary syndrome (PCOS) affects about 10% of women, is often linked to obesity and family history, and can cause irregular periods, fertility issues, and other symptoms. It's usually managed with lifestyle changes, weight loss, and medication.

Routine hysteroscopy isn't needed for women with normal ultrasound results.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

AMH is a promising biomarker for diagnosing PCOS.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

Evaluating various physical and health factors helps diagnose polycystic ovarian syndrome (PCOS).